Table 1.
Author, year | Year(s) of data collection | Country | Study site | Study design | Sampling method | Population | HSV-1 serological assay | Sample size | HSV-1 seroprevalence (%) |
---|---|---|---|---|---|---|---|---|---|
Healthy children populations (n = 21) | |||||||||
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 1–4 years old children | ELISA | 159b | 55.2 |
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 5–9 years old children | ELISA | 159b | 80.5 |
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 10–14 years old children | ELISA | 160b | 86.4 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 1–5 years old males | ELISA | 55 | 60.0 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 6–10 years old males | ELISA | 59 | 74.5 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 1–5 years old females | ELISA | 46 | 50.0 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 6–10 years old females | ELISA | 58 | 81.1 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | 6 months-2 years old infants | Nab | 34 | 23.5 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | 3–5 years old children | Nab | 33 | 39.4 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | 6–10 years old children | Nab | 36 | 69.4 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | 11–15 years old children | Nab | 32 | 81.3 |
Healthy adult populations (n = 60) | |||||||||
Ahmed, 199556 | — | Pakistan | Outpatient clinic | CSa | Conv | Healthy controls | EIA | 56 | 73.2 |
Hossain, 198657 | — | KSA | Outpatient clinic | CS | Conv | Pregnant women | IFA | 1,186 | 92.0 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 21–30 years old males | ELISA | 48 | 85.4 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | >30 years old males | ELISA | 86 | 94.1 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 21–30 years old females | ELISA | 68 | 88.2 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | >30 years old females | ELISA | 43 | 95.3 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Pregnant women | ELISA | 55 | 100 |
Jafarzadeh, 201158 | 2007–08 | Iran | Hospital | CS | Conv | >40 years old blood donors | ELISA | 60 | 33.3 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | 16–20 years old adults | Nab | 32 | 87.5 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | 21–30 years old adults | Nab | 32 | 96.9 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | 31–40 years old adults | Nab | 30 | 100 |
Meguenni, 198955 | — | Algeria | Community | CS | Conv | >40 years old adults | Nab | 35 | 100 |
Memish, 201559 | 2012–13 | KSA | Outpatient clinic | CS | RS | Healthy females | ELISA | 2,157 | 90.9 |
Memish, 201559 | 2012–13 | KSA | Outpatient clinic | CS | RS | Healthy males | ELISA | 2,828 | 87.1 |
Nabipour, 200660 | 2004-04 | Iran | Community | CS | Cluster RS | Healthy males | ELISA | 881 | 83.8 |
Nabipour, 200660 | 2003–04 | Iran | Community | CS | Cluster RS | Healthy female | ELISA | 910 | 88.6 |
Nasrallah, 201847 | 2013–16 | Mixed | Outpatient clinic | CS | Conv | Female blood donors | ELISA | 88 | 84.1 |
Nasrallah, 201847 | 2013–16 | Pakistan | Outpatient clinic | CS | RS | Blood donor Pakistani males | ELISA | 200 | 77.0 |
Nasrallah, 201847 | 2013–16 | Iran | Outpatient clinic | CS | Conv | Blood donor Iranian males | ELISA | 113 | 81.4 |
Nasrallah, 201847 | 2013–16 | Sudan | Outpatient clinic | CS | Conv | Blood donor Sudanese males | ELISA | 129 | 90.7 |
Nasrallah, 201847 | 2013–16 | Yemen | Outpatient clinic | CS | Conv | Blood donor Yemeni males | ELISA | 148 | 92.6 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | ≤24 years old blood donor Egyptians males | ELISA | 50 | 92.0 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | 25–29 years old blood donor Egyptians males | ELISA | 50 | 100 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | 30–34 years old blood donor Egyptians males | ELISA | 50 | 98.0 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | 35–39 years old blood donor Egyptians males | ELISA | 50 | 98.0 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | 40–44 years old blood donor Egyptians males | ELISA | 50 | 98.0 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | 45–49 years old blood donor Egyptians males | ELISA | 50 | 100 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | 50–54 years old blood donor Egyptians males | ELISA | 39 | 94.9 |
Nasrallah, 201847 | 2013–16 | Egypt | Outpatient clinic | CS | Conv | ≥55 years old blood donor Egyptians males | ELISA | 19 | 100 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | ≤24 years old blood donor Qatari males | ELISA | 50 | 70.0 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | 25–29 years old blood donor Qatari males | ELISA | 50 | 62.0 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | 30–34 years old blood donor Qatari males | ELISA | 50 | 80.0 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | 35–39 years old blood donor Qatari males | ELISA | 50 | 82.0 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | 40–44 years old blood donor Qatari males | ELISA | 50 | 84.0 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | 45–49 years old blood donor Qatari males | ELISA | 50 | 96.0 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | 50–54 years old blood donor Qatari males | ELISA | 50 | 92.0 |
Nasrallah, 201847 | 2013–16 | Qatar | Outpatient clinic | CS | Conv | ≥55 years old blood donor Qatari males | ELISA | 50 | 92.0 |
Nasrallah, 201847 | 2013–16 | Jordan | Outpatient clinic | CS | Conv | Blood donor Jordanian males | ELISA | 200 | 86.5 |
Nasrallah, 201847 | 2013–16 | Palestine | Outpatient clinic | CS | Conv | Blood donor Palestinians males | ELISA | 200 | 80.5 |
Nasrallah, 201847 | 2013–16 | Syria | Outpatient clinic | CS | Conv | Blood donor Syrian males | ELISA | 200 | 88.5 |
Nasrallah, 201847 | 2013–16 | Lebanon | Outpatient clinic | CS | Conv | Blood donor Lebanese males | ELISA | 118 | 81.4 |
Obeid, 200761 | 2004–04 | KSA | Hospital | CS | Conv | Pregnant women | ELISA | 459 | 84.1 |
Patnaik, 200762 | — | Morocco | Hospital | CS | Conv | Pregnant women | WB | 169 | 98.8 |
Pourmand, 200963 | — | Iran | Outpatient clinic | CS | Conv | Pregnant women | ELISA | 65 | 55.4 |
Ziyaeyan, 200764 | — | Iran | Hospital | CS | Conv | 16–20 years old pregnant women | Nab | 104 | 83.6 |
Ziyaeyan, 200764 | — | Iran | Hospital | CS | Conv | 21–25 years old pregnant women | Nab | 125 | 94.4 |
Ziyaeyan, 200764 | — | Iran | Hospital | CS | Conv | 26–30 years old pregnant women | Nab | 113 | 90.3 |
Ziyaeyan, 200764 | — | Iran | Hospital | CS | Conv | 31–35 years old pregnant women | Nab | 44 | 95.4 |
Ziyaeyan, 200764 | — | Iran | Hospital | CS | Conv | 36–40 years old pregnant women | Nab | 14 | 100 |
Healthy age-mixed populations (n = 5) | |||||||||
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 11–20 years old males | ELISA | 57 | 77.1 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | 11–20 years old females | ELISA | 134 | 83.6 |
RezaeiC, 201265 | 2010–11 | Iran | Outpatient clinic | CS | Cluster RS | Healthy population | ELISA | 800 | 58.4 |
RezaeiC, 201266 | 2010–11 | Iran | Outpatient clinic | CS | Cluster RS | <85 years old patients | ELISA | 200 | 65.5 |
Clinical adult populations (n = 20) | |||||||||
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Patients with labials herpes | ELISA | 36 | 100 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Patients with atherosclerosis | ELISA | 60 | 100 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Kidney transplant patients | ELISA | 32 | 96.9 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Patients with herpetic keratitis | ELISA | 14 | 85.7 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Patients with STDs | ELISA | 21 | 90.5 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Patients with cervical cancer | ELISA | 51 | 100 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | HIV positive patients | ELISA | 25 | 96.0 |
Jafarzadeh, 201158 | 2007–08 | Iran | Hospital | CS | Conv | Patients with myocardial infarction | ELISA | 120 | 60.8 |
Janier, 199967 | 1994–94 | Mixed | Outpatient clinic | CS | Conv | Patients with STDs | EIA | 99 | 98.9 |
Clinical age-mixed population (n = 4) | |||||||||
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Patients with encephalitis | ELISA | 51 | 58.8 |
Ibrahim, 200054 | 1995–98 | Syria | Outpatient clinic | CS | Conv | Patients with meningitis | ELISA | 21 | 85.7 |
Other populations (n = 10) | |||||||||
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 15–19 years old healthy and HIV infected adults | ELISA | 494b | 92.2 |
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 20–29 years old healthy and HIV infected adults | ELISA | 494b | 92.1 |
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 30–34 years old healthy and HIV infected adults | ELISA | 494b | 95.0 |
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 35–39 years old healthy and HIV infected adults | ELISA | 494b | 98.8 |
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | 40–45 years old healthy and HIV infected adults | ELISA | 494b | 100 |
Cowan, 200353 | 1998–00 | Morocco | Outpatient clinic | CS | Conv | >45 years old healthy and HIV infected adults | ELISA | 493b | 100 |
Ibrahim, 200054 | 1995–98 | Syria | Community | CS | Conv | Female sex workers | ELISA | 54 | 100 |
Ibrahim, 200054 | 1995–99 | Syria | Community | CS | Conv | Female sex workers | ELISA | 47 | 100 |
Ibrahim, 200054 | 1995–100 | Syria | Community | CS | Conv | Arab bar-girls | ELISA | 50 | 98.0 |
Ibrahim, 200054 | 1995–101 | Syria | Community | CS | Conv | Foreign bar-girls | ELISA | 75 | 92.0 |
aActual study design was cohort but the extracted seroprevalence measure was for the baseline measurement.
bStudy included overall sample size, but no individual strata sample sizes. Each stratum sample size was assumed equal to overall sample size divided by the number of strata in the study.
Abbreviations: Conv = Convenience, CS = Cross-sectional, EIA = Enzyme immunoassay, ELISA = Enzyme-linked immunosorbent assay, HIV = Human immunodeficiency virus, HSV-1 = Herpes simplex virus type 1, IFA = Indirect fluorescent assay, KSA = Kingdom of Saudi Arabia, Nab = Neutralization test with neutralizing antibody, RS = Random sampling, STD = Sexually transmitted disease, TORCH = Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus, and herpes infections, WB = Western blot.